Organic Process Research and Development p. 849 - 857 (2015)
Update date:2022-08-28
Topics:
Zhai, Li-Hai
Guo, Li-Hong
Luo, Yang-Hui
Ling, Yang
Sun, Bai-Wang
The discovery and development of an efficient synthesis route to axinitib is reported. The first-generation route researched by Pfizer implemented two Pd-catalyzed coupling reactions as key steps. In this work, the development of Heck-type and C-S coupling reactions catalyzed by CuI is briefly described, using an economial and practical protocol. Aspects of this route, such as selecting optimal ligands, solvent, and other conditions, are discussed in detail. The scale-up experiment was carried out to provide more than 300 g of active pharmaceutical ingredients of axitinib in Form XLI with 99.9% purity in 39% yield. In short, we provide a new choice of synthesis route to axitinib, through two copper-catalyzed coupling reactions with good yield.
View MoreJiangsu Hualun Chemical Industry Co., Ltd
website:http://www.hualunchem.com
Contact:+86-0514-86464168 86507985
Address:39# Middle Renmin Road, Dinghuo Town
Nanjing CoreTech Biomedical Co.,Ltd
Contact:86-025-84989826/ 52880806
Address:No.18 Zhilan Road ,Jiangning District , Nanjing
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Contact:Tel: +86-25-58353800
Address:23 Lijing Road, Nanjing Hi-Tech Zone, Nanjing, Jiangsu, China, 210061
Doi:10.1134/S1070363218020251
(2018)Doi:10.1515/znb-2010-0217
(2010)Doi:10.1016/S0040-4020(01)00547-6
(2001)Doi:10.1248/cpb.37.502
(1989)Doi:10.1021/jo501282h
(2014)Doi:10.1016/S0040-4039(00)61423-5
(1993)